{
  "drug_name": "Insulin",
  "url": "https://wikem.org/wiki/Insulin",
  "scraped_at": "2026-01-10T07:55:35.420778",
  "sections": {
    "Types": {
      "text": "",
      "subsections": {
        "Common_Anti-hyperglycemic_Drugs_and_Pharmacology": {
          "text": "See also\nGLP-1 agonists",
          "tables": [
            [
              {
                "Drug": "Onset",
                "Pharmacology": "Peak"
              },
              {
                "Drug": "Rapid-acting insulinAspart (Novolog)Lispro (Humalog)",
                "Pharmacology": "15-30min"
              },
              {
                "Drug": "Short-acting insulinRegular",
                "Pharmacology": "30-60min"
              },
              {
                "Drug": "Intermediate-acting insulinNPH (Humulin, Novolin)",
                "Pharmacology": "1-3h"
              },
              {
                "Drug": "Long-acting insulinGlargine (Lantus)",
                "Pharmacology": "2-4h"
              },
              {
                "Drug": "SulfonylureaGlimepirideGlipizide (Glucotrol)Glyburide (Glycron, Micronase)",
                "Pharmacology": "–"
              }
            ]
          ]
        }
      },
      "tables": [
        [
          {
            "Type": "RAPID ACTING"
          },
          {
            "Type": "Lispro(humalog)",
            "Onset of action (h)": "0.25-0.5",
            "Peak action": "0.5-1.25",
            "Effective duration": "3-4",
            "Max duration": "4-6"
          },
          {
            "Type": "Aspart(novolog)",
            "Onset of action (h)": "0.25-0.5",
            "Peak action": "0.5-1.25",
            "Effective duration": "3-4",
            "Max duration": "4-6"
          },
          {
            "Type": "Glulisine(apidra)",
            "Onset of action (h)": "0.25-0.5",
            "Peak action": "0.25-1.25",
            "Effective duration": "3-4",
            "Max duration": "4-6"
          },
          {
            "Type": "SHORT ACTING"
          },
          {
            "Type": "Regular",
            "Onset of action (h)": "0.5-1",
            "Peak action": "2-3",
            "Effective duration": "3-6",
            "Max duration": "6-8"
          },
          {
            "Type": "INTERMEDIATE ACTING"
          },
          {
            "Type": "NPH",
            "Onset of action (h)": "2-4",
            "Peak action": "6-10",
            "Effective duration": "10-16",
            "Max duration": "14-18"
          },
          {
            "Type": "LONG ACTING"
          },
          {
            "Type": "glargine(Lantus)",
            "Onset of action (h)": "3-4",
            "Peak action": "8-16",
            "Effective duration": "18-20",
            "Max duration": "20-24"
          },
          {
            "Type": "detemir(Levemir)",
            "Onset of action (h)": "3-4",
            "Peak action": "6-8",
            "Effective duration": "14",
            "Max duration": "~20"
          }
        ]
      ],
      "links": [
        {
          "text": "GLP-1 agonists",
          "url": "https://wikem.org/wiki/GLP-1_agonists"
        }
      ]
    },
    "Common_Anti-hyperglycemic_Drugs_and_Pharmacology": {
      "text": "See also\nGLP-1 agonists",
      "subsections": {},
      "tables": [
        [
          {
            "Drug": "Onset",
            "Pharmacology": "Peak"
          },
          {
            "Drug": "Rapid-acting insulinAspart (Novolog)Lispro (Humalog)",
            "Pharmacology": "15-30min"
          },
          {
            "Drug": "Short-acting insulinRegular",
            "Pharmacology": "30-60min"
          },
          {
            "Drug": "Intermediate-acting insulinNPH (Humulin, Novolin)",
            "Pharmacology": "1-3h"
          },
          {
            "Drug": "Long-acting insulinGlargine (Lantus)",
            "Pharmacology": "2-4h"
          },
          {
            "Drug": "SulfonylureaGlimepirideGlipizide (Glucotrol)Glyburide (Glycron, Micronase)",
            "Pharmacology": "–"
          }
        ]
      ],
      "links": [
        {
          "text": "GLP-1 agonists",
          "url": "https://wikem.org/wiki/GLP-1_agonists"
        }
      ]
    },
    "Insulin_Sliding_Scale": {
      "text": "Dosing depends on the patient's level of insulin resistance.\nThe example sliding scales are for regular insulin with blood glucose (BG) measured in mg/dL",
      "subsections": {
        "Low_Dose_(Renal_Insufficiency)": {
          "text": "BG 150-199: 1 unit bolus Insulin\nBG 200-249: 2 units bolus Insulin\nBG 250-299: 3 units bolus Insulin\nBG 300-349: 4 units bolus Insulin\nBG Over 350: 5 units bolus Insulin",
          "tables": []
        },
        "Medium_Dose_(Standard)": {
          "text": "BG 150-199: 1 unit bolus Insulin\nBG 200-249: 3 units bolus Insulin\nBG 250-299: 5 units bolus Insulin\nBG 300-349: 7 units bolus Insulin\nBG Over 350: 8 units bolus Insulin",
          "tables": []
        },
        "High_Dose_(Severely_Insulin_Resistant)": {
          "text": "BG 150-199: 2 unit bolus Insulin\nBG 200-249: 4 units bolus Insulin\nBG 250-299: 7 units bolus Insulin\nBG 300-349: 10 units bolus Insulin\nBG Over 350: 12 units bolus Insulin",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "See_Also": {
      "text": "Diabetes (Main)",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Diabetes (Main)",
          "url": "https://wikem.org/wiki/Diabetes_(Main)"
        }
      ]
    }
  }
}